GENE TRANSFER TO HEMATOPOIETIC STEM CELLS: Implications for Gene Therapy of Human Disease
- 1 February 1996
- journal article
- review article
- Published by Annual Reviews in Annual Review of Medicine
- Vol. 47 (1), 11-20
- https://doi.org/10.1146/annurev.med.47.1.11
Abstract
▪ Abstract Transfer of new genetic material to hematopoietic stem cells and expression of the gene product in daughter cells of various lineages is an exciting approach to the treatment of congenital and acquired human diseases. This review summarizes the current status of retroviral and adeno-associated viral vectors for gene transfer to human hematopoietic cells, including extensive preclinical data as well as preliminary results from ongoing clinical trials.Keywords
This publication has 33 references indexed in Scilit:
- Tissue-Specific Targeting of Retroviral Vectors Through Ligand-Receptor InteractionsScience, 1994
- Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patientsThe Lancet, 1993
- Gene-marking to trace origin of relapse after autologous bone-marrow transplantationThe Lancet, 1993
- Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer.The Journal of Experimental Medicine, 1992
- Selection of Drug-Resistant Bone Marrow Cells in Vivo After Retroviral Transfer of Human MDR 1Science, 1992
- Human gene therapy comes of ageNature, 1992
- Retroviral gene transfer to primitive normal and leukemic hematopoietic cells using clinically applicable procedures.Journal of Clinical Investigation, 1992
- The ADA Human Gene Therapy Clinical Protocol Original Covering Memo: February 23, 1990Human Gene Therapy, 1990
- Comparison of the Effects of Growth Factors on Retroviral Vector-Mediated Gene Transfer and the Proliferative Status of Human Hematopoietic Progenitor CellsHuman Gene Therapy, 1990
- Retrovirus Packaging CellsHuman Gene Therapy, 1990